Researchers, Regulators, Industry, Consumer Advocates Gather to Discuss Critical Issues Facing the Pharmaceutical Industry

ARLINGTON, Va.- Unexpected liver damage caused by a new treatment for diabetes, life-threatening side-effects from weight loss drugs, disfiguring skin problems seen with a recently approved AIDS treatment- what do these events have in common? In each case, the serious adverse effects of a newly approved treatment only came to light after the drugs entered the marketplace. And in each case, the current clinical trial and drug approval system was put under scrutiny.

Unexpected adverse reactions to recently approved prescription and over the counter drugs, along with dangerous interactions among otherwise safe drugs highlight some of the issues now facing the consortium of academic researchers, regulatory officials and pharmaceutical industry representatives who together make up the world of new drug development.

Members of the media will have an unprecedented opportunity to hear and interview leading authorities from all of these sectors as they gather to discuss these and other issues at the annual meeting of the American Academy of Pharmaceutical Physicians.

"While there may be increased pressures to get new drugs to patients faster, these must be balanced with the need to perform ethical and safe clinical studies. This year's AAPP conference brings together an excellent roster of true experts from all side of the drug development world for frank discussion of current and future issues in drug development, a crucial but often overlooked field of medicine, said David Shapiro, MD, Vice-President and Trustee, American Academy of Pharmaceutical Physicians.

Some of the leading issues that will be discussed include:

    Pediatrics: In light of the new FDA requirements for pediatric studies, how can the safety and efficacy of drugs intended for pediatric patients be evaluated in clinical trials without putting children at risk?

    AIDS: Has pressure on the FDA to 'fast track' new AIDS treatments put patients at risks of adverse reactions

Contact: Linda Packard
American Academy of Pharmaceutical Physicians

Page: 1 2

Related biology news :

1. Worm Wizardry: Worlds Most Heat-Tolerant Creature Suggests Enzymes For Drugs OrIndustry, UD Prof Says
2. Consumer education and development of bio-sensitive alternatives can revive the plastics industry
3. Consumerism, e-commerce and biotechnology to cause changes in health system over next decade, says PricewaterhouseCoopers study
4. Consumers, health experts desire benefits of biotech foods and concur with current FDA labeling policy
5. Emu Meat Not A Popular Choice Among Consumers, Study Shows
6. Formaldehyde Emissions From Consumer Products
7. Consumer-Oriented Environmental Policy Unsuccessful
8. IFT Report Describes Challenges Of Food Industry Stepping Up To The P(a)lates Of Consumers
9. Early Tests Indicate Motor Skills Unharmed In Consumers Of Tainted Fish
10. Worlds Largest Gathering Of Plant Scientists To Meet In St.Louis, August 1-7, 1999
11. "Health Of Hanford" Conference Gathers Diverse Audience To Review And Discuss Health Issues

Post Your Comments:

(Date:7/31/2018)... (PRWEB) , ... July 31, 2018 , ... GSL ... connect seamlessly with LabArchives , the leading cloud-based Electronic Lab Notebook (ELN) platform. ... LabArchives enables researchers to store all of their research data records in a secure, ...
(Date:7/28/2018)... ... 2018 , ... Inthirani Arul, an evidence-based healer, today announces research results based ... autoimmune disorders. , Biomarkers for immune function, blood, as well as, inflammation, were ... 110% increase in overall immunity as seen by the rise in antibody levels , ...
(Date:7/26/2018)... ... , ... The Conference Forum has confirmed the agenda for the 5th Annual ... the Marriott Copley Place in Boston, MA. , Daniel Karlin, MD, Head of Experimental ... to lead the discussion on how and when to implement mobile/digital technology in clinical ...
Breaking Biology News(10 mins):
(Date:7/25/2018)... (PRWEB) , ... July 25, 2018 , ... ... a biofield energy treated proprietary nutraceutical to combat inflammation and autoimmune disorders. ... as, immune function response. The following data was reported:, ...
(Date:7/24/2018)... ... 2018 , ... Mark Stutheit, an evidence-based energy healer, today ... improve anti-inflammatory, and immune function responses. , Biomarkers for systemic and organ-specific inflammation, ... reduced. Results are as follows:, , More than 40% ...
(Date:7/22/2018)... ... July 19, 2018 , ... Mitotech S.A, ... Essex Bio-Investment for Phase 3 clinical program in Dry Eye Disease. Under the ... with approximately $17m allocated towards the first Phase 3 study starting as early ...
(Date:10/12/2017)... ... October 12, 2017 , ... They call it ... biological network, a depiction of a system of linkages and connections so complex ... associate professor of computer science at Worcester Polytechnic Institute (WPI) and director of ...
Breaking Biology Technology:
Cached News: